ArticleBlood advancesPublished
Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- Counties
- Mercer County, Montgomery County
Publication record
- Type
- Article
- Venue
- Blood advances
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Piperidines; Pyrazoles; Pyrimidines; Adenine; Treatment Outcome; Retrospective Studies; Aged; Aged, 80 and over; Middle Aged; Female; Male
- PubMed ID
- 40353821
- PubMed Central ID
- PMC12311590
- Open access
- Yes, open
- Added to directory
- Source checked